Publications by authors named "Erin MacRae"

Claim this Profile
P
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.
Vishnu Prasath, Hinda Boutrid, Robert Wesolowski, Mahmoud Abdel-Rasoul, Cynthia Timmers, Erin Macrae

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
Dionisia Quiroga, Robert Wesolowski, Sara Zelinskas, Ashley Pinette, Brooke Benner, Erin Macrae

Cancer Control· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update.
Harold J Burstein, Mark R Somerfield, Debra L Barton, Ali Dorris, Lesley J Fallowfield, Erin R Macrae

J Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells.
Heather A Parsons, Erin R Macrae, Hao Guo, Tianyu Li, William T Barry

JCO Precis Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib and Trametinib in Patients With Tumors With Mutations: Results of the NCI-MATCH Trial Subprotocol H.
April K S Salama, Shuli Li, Erin R Macrae, Jong-In Park, Edith P Mitchell

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study.
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, Abigail Shoben, Meng Zhao, Erin Macrae

Oncologist· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic breast cancer patient perceptions of somatic tumor genomic testing.
Elizabeth J Adams, Sarah Asad, Raquel Reinbolt, Katharine A Collier, Mahmoud Abdel-Rasoul, Erin R Macrae

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
Robert Wesolowski, Andrew Stiff, Dionisia Quiroga, Christopher McQuinn, Zaibo Li, Erin Macrae

BMC Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Decision Analysis Study of Clinical Genomic Testing in Metastatic Breast Cancer: Impact on Outcomes and Patient Perceptions.
Daniel G Stover, Raquel E Reinbolt, Elizabeth J Adams, Sarah Asad, Katlyn Tolliver, Erin R Macrae

JCO Precis Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.
Robert Wesolowski, Megan C Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Erin R Macrae

Cancer Immunol Immunother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.
Huayang Liu, James A Dowdle, Safiya Khurshid, Nicholas J Sullivan, Nicholas Bertos, Erin R Macrae

Dev Cell· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline.
Hope S Rugo, R Bryan Rumble, Erin Macrae, Debra L Barton, Hannah Klein Connolly

J Clin Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo.
Enrico Caserta, Onur Egriboz, Hui Wang, Chelsea Martin, Christopher Koivisto, Erin R Macrae

Genes Dev· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Michael J Berger, Craig Vargo, Mary Vincent, Katy Shaver, Gary Phillips, Erin Macrae

Support Care Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogen-activated protein kinase signaling controls basal and oncostatin M-mediated JUNB gene expression.
Mellissa J Hicks, Qiuping Hu, Erin Macrae, James DeWille

Mol Cell Biochem· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials.
Mellissa Hicks, Erin R Macrae, Mahmoud Abdel-Rasoul, Rachel Layman, Susan Friedman

Oncologist· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.
Meng Zhao, Xueliang Pan, Rachel Layman, Maryam B Lustberg, Ewa Mrozek, Erin R Macrae

Invest New Drugs· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer.
Drew R Oostra, Erin R Macrae

Breast Cancer (Dove Med Press)· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JUNB promotes the survival of Flavopiridol treated human breast cancer cells.
Mellissa Hicks, Qiuping Hu, Erin Macrae, James DeWille

Biochem Biophys Res Commun· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-related mortality with everolimus in cancer patients.
Robert Wesolowski, Mahmoud Abdel-Rasoul, Maryam Lustberg, Maria Paskell, Charles L Shapiro, Erin R Macrae

Oncologist· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertuzumab in Combination with Trastuzumab and Chemotherapy in the Treatment of HER2-Positive Metastatic Breast Cancer: Safety, Efficacy, and Progression Free Survival.
Joseph J Maly, Erin R Macrae

Breast Cancer (Auckl)· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.
Maryam B Lustberg, Priya Balasubramanian, Brandon Miller, Alejandra Garcia-Villa, Clayton Deighan, Erin R Macrae

Breast Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and duration of chemotherapy in patients with metastatic breast cancer according to tumor subtype and line of therapy.
Davinia S E Seah, Ines Vaz Luis, Erin Macrae, Jessica Sohl, Georgia Litsas

J Natl Compr Canc Netw· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products.
Robert Hay, Erin MacRae, Duane Barber, Moosa Khalil, Douglas J Demetrick

Arch Pathol Lab Med· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis